Abstract: Loss of heterozygosity (LOH) has been frequently detected at chromosome 7q31 region in human head and neck squamous cell carcinomas (HNSCC) and many other cancers, suggesting the existence of the tumor suppressor genes (TSG). However, the targeted gene was yet identified. We analyzed LOH at 7q31 region in 49 HNSCC by using 6 polymorphic microsatellite markers and found allelic deletion in 48% of the informative cases. We detected two preferentially deleted locations one around D7S643 and the other around D7S486. When we redefined the map of 7q31 region according to the contiguous sequences, an ING1 like gene, ING3, which we named it due to homology to ING1, was found in the proximity of D7S643. ING3 protein harbors a PHD zinc finger domain highly homologous among ING family proteins, in which we previously found mutations in a related gene, ING1. As only one missense mutation of the ING3 gene was found in HNSCC, we examined the mRNA expression levels. RT-PCR analysis demonstrated decreased or no expression of ING3 mRNA in 45 % of primary tumors as compared with that of mathced normal samples. All these findings suggest a possibility that ING3 functions as a TSG in a subset of HNSCC.
Introduction
Tumor Suppressor Genes are defined as genetic elements whose loss or mutational inactivation allows cells to acquire neoplastic growth. Cytogenetic studies have shown frequent chromosome 7 abnormalities in human head and neck carcinomas. However, the candidate gene was not identified in this region. In this study, we examined the 7q22-31 region by using a set of highly polymorphic microsatellite markers to find out allelic loss in HNSCC. In light of LOH analysis, we redefined the map of chromosome 7q31 region and examined some genes on this region by analyzing mutation and mRNA expression. The results suggested that the ING3 gene is a likely candidate for one of the TSGs at 7q31 region.
Materials and Methods
Tissue samples: Paired normal and tumor samples were obtained from 49 patients with primary HNSCC operated at Okayama University Hospital. Microsatellite Analysis: Six highly polymorphic primers, D7S480, D7S643, D7S522, D7S486, D7S525 and D7S1799 were used for PCR amplification and LOH analysis. DNA and RNA extractions: Genomic DNAs were isolated from frozen tissues by SDS/proteinase K treatment, phenol-chloroform extraction and ethanol precipitation. Total RNAs were prepared by using ISOGEN. Quantification of the RT-PCR products: ING3 mRNA expression in tumor and in normal tissues was examined by the duplex RT-PCR method. PCR products were separated through 2% agarose gel and stained with ethidium bromide. The intensity of ethidium bromide staining of each band was measured by a CCD image sensor and anlyzed by a computer program for band quantification. Luciferase Assay was used for promoter activity and PCR-SSCP analysis was performed for mutation detection.
Results and Discussion
We examined LOH using six microsatellite markers on the chromosome 7q22-31 region in paired normal and HNSCC DNAs. Overall, 48% (22/46) samples showed LOH at least one marker on 7q31. We detected two distinct regions of deletion. Markers D7S643 and D7S486 showed the highest incidence of LOH with a value of 35%, while flanking markers demonstrated lower frequency (Figure 1) . We analyzed the promoter for the ING3 gene, the 5' flanking 1.5kb region including 5'noncoding region of exon1 was subcloned in sense or antisense orientation. Luciferase construct in sence orientation showed about 213-fold increase in luciferase plasmid, while activity of luciferase construct in antisense orientation was not detectable. Analysis of a candidate tumor suppressor gene, ING3, at 7q31 demonstrated reduced 
